Login
Register
Submit a Paper
Propose a Special lssue
Open Access
RESIDENT’S CORNER
Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male
Department of Urology, Brookdale University Hospital and Medical Center, Brooklyn, New York, USA
Address correspondence to Dr. Shahab Hillyer, Department
of Urology, Brookdale University Hospital, 1 Brookdale
Plaza, Brooklyn, New York 11212 USA
Canadian Journal of Urology 2009, 16(5), 4866-4869.
Download PDFAbstract
Objective: Transitional cell carcinoma of the bladder is commonly treated with intravesical BCG. We report a cutaneous complication of BCG after therapy in 66-year-old male 4 years after initiating treatment.Materials and methods: A case review including pathological slides, laboratory data, and radiographic findings.
Results: Biopsy findings showed an ill defined granulomatous process with chronic inflammation and necrosis.
Conclusion: The patient was managed on antituberculous therapy for a period of 6 months with resolution of symptoms.
Keywords
BCG therapy, superfi cial bladder cancer, penile lesion
Cite This Article
APA Style
Hillyer, S., Gulmi, F.A. (2009). Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male. Canadian Journal of Urology, 16(5), 4866–4869.
Vancouver Style
Hillyer S, Gulmi FA. Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male. Can J Urology. 2009;16(5):4866–4869.
IEEE Style
S. Hillyer and F.A. Gulmi, “Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male,” Can. J. Urology, vol. 16, no. 5, pp. 4866–4869, 2009.
Copyright © 2009 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
